Sigma-1 receptor: a potential new target for Parkinson′s disease?
Open Access
- 1 January 2014
- journal article
- perspective
- Published by Medknow in Neural Regeneration Research
- Vol. 9 (21) , 1882-3
Abstract
Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,ChinaKeywords
This publication has 11 references indexed in Scilit:
- Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonismBrain, 2014
- Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathyExperimental Neurology, 2012
- The neuropathology of genetic Parkinson's diseaseMovement Disorders, 2012
- Astrocytes and Therapeutics for Parkinson's DiseaseNeurotherapeutics, 2010
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic interventionNeurobiology of Disease, 2010
- The pharmacology of sigma-1 receptorsPharmacology & Therapeutics, 2009
- Why have we failed to achieve neuroprotection in Parkinson's disease?Annals of Neurology, 2009
- Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell SurvivalCell, 2007
- BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disordersTrends in Neurosciences, 2004
- Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's diseaseBrain Research, 1990